The MHRA-approved dosing schedule involves gradual titration, starting at 0.25 mg once weekly for 4 weeks, then increasing to 0.5 mg once weekly, with further increases to 1 mg or 2 mg possible after at least 4 weeks at each dose level
This would potentially provide the first mechanism-specific therapeutic option for bronchiectasis patients
Always consult with qualified healthcare professionals before starting any peptide therapy protocol
Ill have my morning coffee, and then it could be 2PM, and Ill realize, Oh, I havent eaten yet, she says
Larger randomized placebo-controlled trials including a variety of patient populations (ie, those with metabolic syndrome versus those without) are needed to confirm efficacy of GLP-1RAs according to patient type
To qualify for an exemption, the preparation of peptides must follow the receipt of a valid prescription for a specific patient, and strictly meet the requirements outlined in Schedule 8 of the Therapeutic Goods Regulations 1990 (Cth)